NATURALLY PROCESSED PEPTIDES FROM 2 DISEASE-RESISTANCE-ASSOCIATED HLA-DR13 ALLELES SHOW RELATED SEQUENCE MOTIFS AND THE EFFECTS OF THE DIMORPHISM AT POSITION-86 OF THE HLA-DR-BETA CHAIN
Mp. Davenport et al., NATURALLY PROCESSED PEPTIDES FROM 2 DISEASE-RESISTANCE-ASSOCIATED HLA-DR13 ALLELES SHOW RELATED SEQUENCE MOTIFS AND THE EFFECTS OF THE DIMORPHISM AT POSITION-86 OF THE HLA-DR-BETA CHAIN, Proceedings of the National Academy of Sciences of the United Statesof America, 92(14), 1995, pp. 6567-6571
HLA-DR13 has been associated with resistance to two major infectious d
iseases of humans, To investigate the peptide binding specificity of t
wo HLA-DR13 molecules and the effects of the Gly/Val dimorphism at pos
ition 86 of the HLA-DR beta chain on natural peptide ligands, these pe
ptides were acid-eluted from immunoaffinity-purified HLA-DRB11301 and
-DRB11302, molecules that differ only at this position, The eluted p
eptides were subjected to pool sequencing or individual peptide sequen
cing by tandem MS or Edman microsequencing, Sequences were obtained fo
r 23 peptides from nine source proteins, Three pool sequences for each
allele and the sequences of individual peptides were used to define b
inding motifs for each allele, Binding specificities varied only at th
e primary hydrophobic anchor residue, the differences being a preferen
ce for the aromatic amino acids Tyr and Phe in DRB11302 and a prefere
nce for Val in DRB11301, Synthetic analogues of the eluted peptides s
howed allele specificity in their binding to purified HLA-DR, and Ala-
substituted peptides were used to identify the primary anchor residues
for binding. The failure of some peptides eluted from DRB1:':1302 (th
ose that use aromatic amino acids as primary anchors) to bind to DRB1
1301 confirmed the different preferences for peptide anchor residues c
onferred by the Gly --> Val change at position 86, These data suggest
a molecular basis for the differential associations of HLA-DRB11301 a
nd DRB11302 with resistance to severe malaria and clearance of hepati
tis B virus infection.